Abdel Abdel-Rahman | Cardiovascular Pharmacology | Innovative Research Award

Innovative Research Award

Abdel Abdel-Rahman
East Carolina University, United States
Abdel Abdel-Rahman
Affiliation East Carolina University
Country United States
Scopus ID 7102847207
Documents 181
Citations 3711
h-index 33
Subject Area Cardiovascular Pharmacology
Event International Popular Scientist Awards
ORCID
0000-0002-3461-2190

Abdel Abdel-Rahman  the Innovative Research Award recognizes distinguished scientific contributions in the field of cardiovascular pharmacology and related biomedical sciences. Abdel Abdel-Rahman of East Carolina University has developed an extensive scholarly portfolio that reflects sustained academic productivity, interdisciplinary collaboration, and measurable scientific impact in cardiovascular research and pharmacological sciences.[1] His publication record, citation performance, and recognized expertise in cardiovascular pharmacology position him as a notable contributor within the international scientific community.[2]

Abstract

Abdel Abdel-Rahman has contributed extensively to cardiovascular pharmacology through scholarly investigations addressing vascular physiology, autonomic regulation, pharmacodynamics, and therapeutic mechanisms associated with cardiovascular disorders. His academic output demonstrates a strong emphasis on translational biomedical research and pharmacological innovation.[1] With 181 indexed documents, 3711 citations, and an h-index of 33, his work has achieved significant scholarly visibility and international academic engagement.[2] The Innovative Research Award acknowledges these contributions within the framework of the International Popular Scientist Awards program.

Keywords

The Innovative Research Award in Cardiovascular Pharmacology recognizes pioneering contributions that advance the understanding and treatment of cardiovascular diseases through pharmacological innovation and biomedical discovery. This award celebrates researchers whose work bridges Pharmacological Research, Biomedical Sciences, and Translational Medicine to develop safer, more effective cardiovascular therapeutics. It honors excellence in innovative drug development, clinical applications, and transformative scientific research that improves global cardiovascular health outcomes.

Introduction

Cardiovascular pharmacology remains an essential scientific discipline within biomedical research due to its role in understanding cardiovascular diseases, therapeutic mechanisms, and pharmacological interventions. Research within this domain contributes to the development of treatment strategies for hypertension, vascular dysfunction, and cardiac pathophysiology.[2]

Abdel Abdel-Rahman has maintained a sustained academic presence in this field through research activities associated with East Carolina University. His work demonstrates consistent scholarly productivity and scientific engagement within cardiovascular and pharmacological sciences.[1] The International Popular Scientist Awards recognize researchers whose scientific achievements contribute meaningfully to academic advancement and interdisciplinary biomedical knowledge.

Research Profile

The research profile of Abdel Abdel-Rahman reflects extensive engagement in cardiovascular pharmacology, autonomic regulation, neuropharmacology, and vascular function research. His scientific investigations have addressed mechanisms influencing blood pressure regulation, pharmacological responses, and cardiovascular signaling pathways.[2]

Bibliometric indicators associated with his scholarly output demonstrate sustained academic visibility. According to indexed scholarly databases, his work has accumulated thousands of citations and a notable h-index, indicating both productivity and citation influence within the biomedical research community.[2]

Research Contributions

Abdel Abdel-Rahman’s scientific contributions include investigations into cardiovascular regulation, pharmacological interactions, and neurovascular signaling. His studies have explored physiological mechanisms underlying vascular control and the pharmacodynamics associated with cardiovascular therapeutics.[5]

Several publications associated with his research profile have examined experimental pharmacological models relevant to cardiovascular disease mechanisms and therapeutic responses. These contributions have enhanced understanding of autonomic modulation and vascular pharmacology within preclinical and translational research contexts.[1]

Publications

The publication portfolio of Abdel Abdel-Rahman includes peer-reviewed articles focusing on cardiovascular pharmacology and related biomedical sciences. His indexed research output demonstrates continuity in scientific productivity and interdisciplinary collaboration.[1]

Representative publications indexed within international scholarly databases have contributed to citation growth and broader academic dissemination.[2]

Research Impact

The scientific impact of Abdel Abdel-Rahman’s work is reflected through citation metrics, publication visibility, and continued relevance within cardiovascular pharmacology research. His research output has contributed to ongoing academic discussions concerning cardiovascular physiology, vascular pharmacology, and therapeutic intervention strategies.

An h-index of 33 indicates consistent citation performance across multiple scholarly works, while a citation count exceeding 3700 demonstrates sustained engagement by the international biomedical research community.[2] These indicators collectively support the scholarly significance of his research activities.

Award Suitability

The Innovative Research Award recognizes individuals demonstrating substantial scientific contributions, scholarly influence, and research advancement within their respective disciplines. Abdel Abdel-Rahman’s academic profile aligns with these criteria through sustained publication activity, recognized citation impact, and research contributions within cardiovascular pharmacology.[1]

His scientific work reflects methodological rigor, interdisciplinary relevance, and ongoing contributions to pharmacological sciences. Participation in the International Popular Scientist Awards further highlights the importance of promoting impactful biomedical research and academic excellence.[1]

Conclusion

Abdel Abdel-Rahman’s scholarly record demonstrates a sustained commitment to cardiovascular pharmacology and biomedical research. Through extensive publication activity, measurable citation influence, and interdisciplinary scientific contributions, he has established a recognized academic presence within the international research community.[2] The Innovative Research Award acknowledges these accomplishments within the broader context of scientific advancement and research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: Abdel Abdel-Rahman, Author ID 7102847207. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102847207
  2. ORCID. (n.d.). ORCID profile for Abdel Abdel-Rahman.
    https://orcid.org/0000-0002-3461-2190
  3. International Popular Scientist Awards. (n.d.). Research recognition and scientific excellence initiatives.
    https://popularscientist.com/
  4. Katzung, B. G. (2021). Basic and Clinical Pharmacology. McGraw-Hill Education

Boulais YOVOGAN | Biology and Life Sciences | Best Researcher Award

Dr. Boulais YOVOGAN | Biology and Life Sciences | Best Researcher Award

Medical entomologist and Geneticist Centre de Recherche Entomologique de Cotonou (CREC) Benin

Dr. Boulais Yovogan is a passionate medical entomologist and geneticist based at the Centre de Recherche Entomologique de Cotonou (CREC), Benin. With extensive field and academic experience, Dr. Yovogan has contributed significantly to vector surveillance, malaria control, and genetic resource management. His dynamic role includes research, field coordination, and mentoring students at the University of Abomey-Calavi (UAC). He is also actively involved in international collaborations with institutions like the London School of Hygiene & Tropical Medicine (LSHTM).

Profile

Google Scholar

🎓 Education

Dr. Yovogan earned his PhD in Life Sciences (2024) from the University of Abomey-Calavi (UAC), Benin, specializing in medical entomology and genetic resources. His academic journey blends biological sciences with practical research experience, making him a key contributor to tropical disease research in West Africa.

🧪 Experience

With hands-on expertise in entomological surveillance and vector control, Dr. Yovogan led the transmission component of the New Net Project (2019–2024), under UNITAID and LSHTM. At CREC, he contributes to national and international research initiatives. Simultaneously, he supports teaching at the Zoology Department of UAC, guiding students in technical laboratory handling and tool usage.

🔬 Research Interest

Dr. Yovogan’s core interests lie in vector-borne diseases, especially malaria transmission, insecticide resistance, and vector surveillance methods. He evaluates innovative vector control tools and contributes to improving entomological data collection techniques for enhanced disease control strategies.

🏆 Awards

Although early in his decorated career, Dr. Yovogan is a strong contender for recognition due to his impactful research. His nomination for the Best Researcher Award under the International Popular Scientist Awards underscores his scientific leadership and contributions to public health and vector control.

📚 Publications Top Notes: 

Dr. Boulais Yovogan has authored 33 peer-reviewed articles in reputed journals including Malaria Journal, Plos One, Parasites & Vectors, and BMC Public Health. His research has been cited 313 times, with an h-index of 8 and i10-index of 7. A recent publication includes:

“Evaluation of a dual-active ingredient LLIN against malaria vectors in Benin”
📖 Malaria Journal (2025)Cited by 5 articles

Efficacy of pyriproxyfen-pyrethroid long-lasting insecticidal nets (LLINs) and chlorfenapyr-pyrethroid LLINs compared with pyrethroid-only LLINs for malaria control in Benin: a …

Assessing the efficacy of two dual-active ingredients long-lasting insecticidal nets for the control of malaria transmitted by pyrethroid-resistant vectors in Benin: study …

Pre-intervention characteristics of the mosquito species in Benin in preparation for a randomized controlled trial assessing the efficacy of dual active-ingredient long-lasting …

WHO cone bio-assays of classical and new-generation long-lasting insecticidal nets call for innovative insecticides targeting the knock-down resistance mechanism in Benin

Malaria burden and associated risk factors in an area of pyrethroid-resistant vectors in Southern Benin

Pyrethroid Resistance Intensity in Anopheles gambiae s.l. from Different Agricultural Production Zones in Benin, West Africa

Effectiveness of pyriproxyfen-pyrethroid and chlorfenapyr-pyrethroid long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs for malaria control in the third …

What can be learned from the residual efficacy of three formulations of insecticides (pirimiphos-methyl, clothianidin and deltamethrin mixture, and clothianidin alone) in large …